Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 283
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01551524 | Phase I Study of mPEG-R-Crisantaspase Given IV | ||
| NCT04652115 | Defibrotide for the Treatment of Severe COVID-19 | ||
| NCT00675948 | Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain | ||
| NCT02348606 | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" | ||
| NCT00498485 | Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome | ||
| NCT05055271 | Delphi Consensus Excessive Daytime Sleepiness in OSA | ||
| NCT01322464 | Study to Assess Food Effect on Sativex Bioavailability | ||
| NCT01918735 | A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects | ||
| NCT02150928 | An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) | ||
| NCT03339401 | The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation | ||
| NCT05772429 | Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting | ||
| NCT05392374 | Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas | ||
| NCT00931164 | Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO) | ||
| NCT07290985 | AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas | ||
| NCT00003966 | Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation | ||
| NCT06261502 | Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome | ||
| NCT00628498 | Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study | ||
| NCT01696084 | Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia | ||
| NCT05024552 | Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML | ||
| NCT00594945 | Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures | ||
| NCT05651152 | A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy Participants | ||
| NCT04794491 | An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy | ||
| NCT05875974 | A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy | ||
| NCT05244239 | Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer | ||
| NCT03929666 | A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer | ||
| NCT00713323 | A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain. | ||
| NCT06108050 | JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors | ||
| NCT00711646 | A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis. | ||
| NCT02087306 | Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection | ||
| NCT05126433 | Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors | ||
| NCT02348619 | "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" | ||
| NCT05542407 | ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer | ||
| NCT02348593 | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" | ||
| NCT02718755 | Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies | ||
| NCT00711880 | A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia. | ||
| NCT05122650 | A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) | ||
| NCT00423813 | A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. | ||
| NCT00780182 | Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers | ||
| NCT03101241 | A Phase 2 RCT Study of CX-8998 for Essential Tremor | ||
| NCT02564952 | An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol | ||
| NCT03865589 | Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome | ||
| NCT03295396 | ONC201 in Adults With Recurrent H3 K27M-mutant Glioma | ||
| NCT02257684 | A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) | ||
| NCT07153055 | Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer | ||
| NCT02954887 | Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7) | ||
| NCT04592159 | Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder | ||
| NCT03825796 | CPX-351 Plus Enasidenib for Relapsed AML | ||
| NCT02533115 | EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML | ||
| NCT05009992 | Combination Therapy for the Treatment of Diffuse Midline Gliomas | ||
| NCT04610658 | Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC |
